{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:32:20Z","timestamp":1765827140501},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084173","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T17:36:08Z","timestamp":1387388168000},"page":"e84173","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness"],"prefix":"10.1371","volume":"8","author":[{"given":"Yazdan","family":"Yazdanpanah","sequence":"first","affiliation":[]},{"given":"Julian","family":"Perelman","sequence":"additional","affiliation":[]},{"given":"Madeline A.","family":"DiLorenzo","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Henrique","family":"Barros","sequence":"additional","affiliation":[]},{"given":"C\u00e9u","family":"Mateus","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Kamal","family":"Mansinho","sequence":"additional","affiliation":[]},{"given":"Marion","family":"Robine","sequence":"additional","affiliation":[]},{"given":"Ji-Eun","family":"Park","sequence":"additional","affiliation":[]},{"given":"Eric L.","family":"Ross","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[]},{"given":"Rochelle P.","family":"Walensky","sequence":"additional","affiliation":[]},{"given":"Farzad","family":"Noubary","sequence":"additional","affiliation":[]},{"given":"Kenneth A.","family":"Freedberg","sequence":"additional","affiliation":[]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"ref1","article-title":"Programa Nacional para a; Infe\u00e7\u00e3o VIH\/SIDA. Infe\u00e7\u00e3o VIH\/SIDA: A Situa\u00e7\u00e3o em Portugal a 31 de Dezembro de 2011","year":"2012"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1468-1293.2008.00584.x","article-title":"Diagnosed and undiagnosed HIV-infected populations in Europe","volume":"9","author":"FF Hamers","year":"2008","journal-title":"HIV Med"},{"key":"ref3","article-title":"Health at a Glance 2011: OECD Indicators. OECD Publishing","year":"2011"},{"key":"ref4","article-title":"Resolu\u00e7\u00e3o da assembleia da Rep\u00fablica n\u00ba161\/2011","author":"Rep\u00fablica","year":"2011"},{"key":"ref5","article-title":"D\u00e9pistage de l\u2019infection par le VIH en France: strat\u00e9gies et dispositif de d\u00e9pistage.","year":"2009"},{"key":"ref6","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"B Branson","year":"2006","journal-title":"MMWR. Morb and Mortal Weekly Report"},{"key":"ref7","article-title":"Scaling up HIV testing and counselling in the WHO European Region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support: policy framework","year":"2010"},{"key":"ref8"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/01.aids.0000279714.60935.a2","article-title":"Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy","volume":"21","author":"KA Freedberg","year":"2007","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":"The cost effectiveness of combination antiretroviral therapy for HIV disease","volume":"344","author":"KA Freedberg","year":"2001","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJMsa060247","article-title":"Cost-effectiveness of HIV treatment in resource-poor settings - the case of C\u00f4te d\u2019Ivoire","volume":"355","author":"SJ Goldie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-145-11-200612050-00004","article-title":"Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs","volume":"145","author":"AD Paltiel","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States\u2014 an analysis of cost-effectiveness","volume":"352","author":"AD Paltiel","year":"2005","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/655130","article-title":"Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC","volume":"51","author":"RP Walensky","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QAI.0b013e3181fb8f24","article-title":"The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa","volume":"56","author":"RP Walensky","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1086\/587184","article-title":"Scaling up antiretroviral therapy in South Africa: the impact of speed on survival","volume":"197","author":"RP Walensky","year":"2008","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e13132","DOI":"10.1371\/journal.pone.0013132","article-title":"Routine HIV screening in France: clinical impact and cost-effectiveness","volume":"5","author":"Y Yazdanpanah","year":"2010","journal-title":"PLOS ONE"},{"key":"ref18","article-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"T Tan-Torres Edejer","year":"2003"},{"key":"ref19","article-title":"Cost effectiveness in health and medicine","author":"MR Gold","year":"1996"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/aje\/kwg206","article-title":"Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models","volume":"158","author":"SR Cole","year":"2003","journal-title":"Am J Epidemiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","article-title":"Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness","volume":"134","author":"MC Weinstein","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/344902","article-title":"Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis","volume":"36","author":"Y Yazdanpanah","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjmed.2004.07.055","article-title":"Routine human immunodeficiency virus testing: an economic evaluation of current guidelines","volume":"118","author":"RP Walensky","year":"2005","journal-title":"Am J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"S Attia","year":"2009","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/512816","article-title":"The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men","volume":"44","author":"AW McCormick","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref26","article-title":"Portuguese statistical data for 2009-2011","year":"2011"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e31695","DOI":"10.1371\/journal.pone.0031695","article-title":"Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency","volume":"7","author":"P Frange","year":"2012","journal-title":"PLOS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/088922203766774568","article-title":"Spreading of HIV-1 subtype G and envB\/gagG recombinant strains among injecting drug users in Lisbon, Portugal","volume":"19","author":"A Esteves","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ije\/30.4.864","article-title":"Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts","volume":"30","author":"Y Yazdanpanah","year":"2001","journal-title":"Int J Epidemiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/aje\/153.7.619","article-title":"Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET vaccine preparedness study","volume":"153","author":"GR Seage","year":"2001","journal-title":"Am J Epidemiology"},{"key":"ref31","article-title":"Recomenda\u00e7\u00f5es portuguesas para o tratamento da infec\u00e7\u00e3o; VIH-SIDA","year":"2009"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"JE Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(07)60597-2","article-title":"Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial","volume":"369","author":"B Grinsztejn","year":"2007","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.aids.0000166091.39317.99","article-title":"Atazanavir plus ritonavir or saquinavir, and lopinavir\/ritonavir in patients experiencing multiple virological failures","volume":"19","author":"M Johnson","year":"2005","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.qai.0000185314.56556.c3","article-title":"Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials","volume":"40","author":"M Nelson","year":"2005","journal-title":"J_Acquired Immune Deficiency Syndromes"},{"key":"ref36","article-title":"Efficacy and safety of maraviroc plus optimized background therapy in viremic ART-experienced patients infected with CCR5-tropic HIV-1: 24-week results of a phase 2b\/3 study in the US and Canada [abstract 104bLB]","author":"JP Lalezari","year":"2007"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.aids.0000216371.76689.63","article-title":"96-week comparison of once-daily atazanavir\/ritonavir and twice-daily lopinavir\/ritonavir in patients with multiple virologic failures","volume":"20","author":"M Johnson","year":"2006","journal-title":"AIDS"},{"key":"ref38","article-title":"Direct treatment costs for HIV\/AIDS in Portugal","author":"J Perelman","year":"2013","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"ref39","article-title":"Cat\u00e1logo do aprovisionamento p\u00fablico da sa\u00fade","year":"2013"},{"key":"ref40","article-title":"Contabilidade analitica 2006 hospitais do SNS","author":"Sistema de Sa\u00fade","year":"2007"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1177\/0272989X98018002S11","article-title":"A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection","volume":"18","author":"AD Paltiel","year":"1998","journal-title":"Med Decis Making"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0272989X0202200103","article-title":"Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV\/AIDS","volume":"22","author":"BR Schackman","year":"2002","journal-title":"Med Decis Making"},{"key":"ref43","article-title":"World Economic Outlook Database","year":"2013"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e17502","DOI":"10.1371\/journal.pone.0017502","article-title":"Estimated HIV incidence in the United States, 2006\u20132009","volume":"6","author":"J Prejean","year":"2011","journal-title":"PLOS ONE"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6","volume":"15","author":"AH Briggs","year":"2012","journal-title":"Value Health"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"AH Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"ref47","first-page":"244","article-title":"Bulletin Epidemiologique Hebdomadaire","volume":"33","author":"M Jauffret-Raustide","year":"2006"},{"key":"ref48","author":"J Rodrigues","year":"2011"},{"key":"ref49","article-title":"Portaria n\u00ba 132\/2009","year":"2009","journal-title":"Di\u00e1rio da Rep\u00fablica, 1.\u00aa s\u00e9rie - N.\u00ba 21"},{"key":"ref50","article-title":"CHOosing interventions that are cost-effective (WHO-CHOICE): Cost-effectiveness thresholds","year":"2009"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"C McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMsa042657","article-title":"Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy","volume":"352","author":"GD Sanders","year":"2005","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10198-011-0348-5","article-title":"Budget impact analysis in economic evaluation: a proposal for a clearer definition","volume":"12","author":"L Garattini","year":"2011","journal-title":"Eur J Health Econ"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"BM Mathers","year":"2008","journal-title":"Lancet"},{"key":"ref55"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e13132","DOI":"10.1371\/journal.pone.0013132","article-title":"Routine HIV screening in France: clinical impact and cost-effectiveness: Appendix S1","volume":"5","author":"Y Yazdanpanah","year":"2010","journal-title":"PLOS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T23:10:54Z","timestamp":1564960254000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084173"}},"subtitle":[],"editor":[{"given":"Julian\u00a0W.","family":"Tang","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084173","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}